Olorofim
F901318/0032
Phase 2 small_molecule completed
Quick answer
Olorofim for Invasive Fungal Infections is a Phase 2 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Invasive Fungal Infections
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed